Aquestive Therapeutics, Inc. (AQST)
4.27
+0.04
(+0.95%)
USD |
NASDAQ |
May 07, 14:12
Aquestive Therapeutics SG&A Expense (TTM) : 79.85M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 68.67M |
| REGENXBIO, Inc. | 82.86M |
| Verastem, Inc. | 81.14M |
| Harrow, Inc. | 152.91M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |